What does GENEX - MED do?

GENEX - MED is a general practice in Bertrix. Private Limited, started on 28 August 1998.

What is the address of GENEX - MED?

The registered office of GENEX - MED is located at Rue de la Gare 108, 6880 Bertrix.

Is GENEX - MED still active?

Yes. According to the CBE (30 October 2026) GENEX - MED is active, legal situation “Normale toestand”, started on 28 August 1998.

Is GENEX - MED registered on Peppol?

Yes, GENEX - MED is registered on the Peppol network with ID 0208:0464047307.

What is the enterprise number of GENEX - MED?

The enterprise number of GENEX - MED is BE0464047307.

When was GENEX - MED founded?

GENEX - MED was founded on 28 August 1998.

Who are the directors of GENEX - MED?

According to the 2025 annual accounts, the directors of GENEX - MED are: ALAIN NOEL.

Is GENEX - MED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 August 1998; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did GENEX - MED make in 2025?

GENEX - MED posted a profit after taxes of € 11,433 in financial year 2025.

What is the revenue of GENEX - MED?

As a small company, GENEX - MED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 39,087.

GENEX - MED (Private Limited) - Bertrix - BE0464047307

Dossier GENEX - MED, printed on 30 October 2026 from databakkes.be/en/0464047307/genex-med. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

GENEX - MED from Bertrix, company number BE0464047307, closed financial year 2025 with a result of € 11,433 after tax. For that financial year GENEX - MED recorded a gross margin of € 39,087 and equity of € 343,031. Compared with financial year 2024, the result moved from € 23,543 to € 11,433. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 16, 2026.

What it is worth Growing

€ 343,031

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 11,433

▼ 51% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 153,694

▼ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 323,031.

People and assets in 2025

Vehicles and equipment

€ 7,698

▼ 10% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 3,805

▼ 78% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 10,684

▲ 43% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 13,845

▼ 33% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 84,051 Gross margin 2022: € 84,051 First fiscal year in the series	€ 16,642 Gross margin 2023: € 16,642 ▼ 80% vs 2022 (€ 84,051) Unfavourable step	€ 52,835 Gross margin 2024: € 52,835 ▲ 217% vs 2023 (€ 16,642) Favourable step	€ 39,087 Gross margin 2025: € 39,087 ▼ 26% vs 2024 (€ 52,835) Unfavourable step	▼ 26%
Profit after taxes	€ 45,756 Profit after taxes 2022: € 45,756 First fiscal year in the series	€ -3,306 Profit after taxes 2023: € -3,306 ▼ € 49,062 vs 2022 (€ 45,756) Unfavourable step	€ 23,543 Profit after taxes 2024: € 23,543 ▲ € 26,850 vs 2023 (€ -3,306) Favourable step	€ 11,433 Profit after taxes 2025: € 11,433 ▼ 51% vs 2024 (€ 23,543) Unfavourable step	▼ 51%
Equity	€ 311,361 Equity 2022: € 311,361 First fiscal year in the series	€ 308,055 Equity 2023: € 308,055 ▼ 1% vs 2022 (€ 311,361) Unfavourable step	€ 331,598 Equity 2024: € 331,598 ▲ 8% vs 2023 (€ 308,055) Favourable step	€ 343,031 Equity 2025: € 343,031 ▲ 3% vs 2024 (€ 331,598) Favourable step	▲ 3%
Total debts	€ 75,036 Total debts 2022: € 75,036 First fiscal year in the series	€ 66,116 Total debts 2023: € 66,116 ▼ 12% vs 2022 (€ 75,036) Favourable step	€ 95,493 Total debts 2024: € 95,493 ▲ 44% vs 2023 (€ 66,116) Unfavourable step	€ 75,580 Total debts 2025: € 75,580 ▼ 21% vs 2024 (€ 95,493) Favourable step	▼ 21%
Cash	€ 115,241 Cash 2022: € 115,241 First fiscal year in the series	€ 95,853 Cash 2023: € 95,853 ▼ 17% vs 2022 (€ 115,241) Unfavourable step	€ 154,996 Cash 2024: € 154,996 ▲ 62% vs 2023 (€ 95,853) Favourable step	€ 153,694 Cash 2025: € 153,694 ▼ 1% vs 2024 (€ 154,996) Unfavourable step	▼ 1%
Land & buildings	€ 127,258 Land & buildings 2022: € 127,258 First fiscal year in the series	€ 117,860 Land & buildings 2023: € 117,860 ▼ 7% vs 2022 (€ 127,258) Unchanged	€ 115,221 Land & buildings 2024: € 115,221 ▼ 2% vs 2023 (€ 117,860) Unchanged	€ 105,874 Land & buildings 2025: € 105,874 ▼ 8% vs 2024 (€ 115,221) Unchanged	▼ 8%
Retained profit	€ 291,361 Retained profit 2022: € 291,361 First fiscal year in the series	€ 288,055 Retained profit 2023: € 288,055 ▼ 1% vs 2022 (€ 291,361) Unfavourable step	€ 311,598 Retained profit 2024: € 311,598 ▲ 8% vs 2023 (€ 288,055) Favourable step	€ 323,031 Retained profit 2025: € 323,031 ▲ 4% vs 2024 (€ 311,598) Favourable step	▲ 4%
Bank debt	€ 41,882 Bank debt 2022: € 41,882 First fiscal year in the series	€ 29,815 Bank debt 2023: € 29,815 ▼ 29% vs 2022 (€ 41,882) Favourable step	€ 16,941 Bank debt 2024: € 16,941 ▼ 43% vs 2023 (€ 29,815) Favourable step	€ 3,805 Bank debt 2025: € 3,805 ▼ 78% vs 2024 (€ 16,941) Favourable step	▼ 78%
Balance sheet total	€ 386,397 Balance sheet total 2022: € 386,397 First fiscal year in the series	€ 374,171 Balance sheet total 2023: € 374,171 ▼ 3% vs 2022 (€ 386,397) Unchanged	€ 427,091 Balance sheet total 2024: € 427,091 ▲ 14% vs 2023 (€ 374,171) Unchanged	€ 418,611 Balance sheet total 2025: € 418,611 ▼ 2% vs 2024 (€ 427,091) Unchanged	▼ 2%

Key figures of GENEX - MED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to GENEX - MED?

What happened at GENEX - MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Feb 16, 2026 New annual accounts for financial year 2025: profit of € 11,433 (▼ 51% vs 2024). filed late Source: NBB ↗
Aug 28, 1998 Start of the company according to the CBE. KBO
1998 ALAIN NOEL became a director. NBB

In short

From € 45,756 profit in 2022 to € 11,433 profit in 2025.

Paid € 40,078 in corporate taxes since 2022.

Best year ever: 2022, with € 45,756 profit.

Original PDFs at the National Bank ↗

Management

ALAIN NOEL

GENEX - MED

Behind GENEX - MED is ALAIN NOEL.

Directors

According to the 2025 annual accounts

ALAIN NOEL

Director

since 1998

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Gare 108

6880 Bertrix

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0464.047.307
VAT number: BE 0464.047.307
Registered office: Rue de la Gare 108, 6880 Bertrix
Names & denominations: GENEX - MED
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 28 August 1998
Peppol: Active · Active since 1 Jan 2001
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗